The stroke market

  • The global stroke market was valued at BUSD 8 in 2018 according to Transparency Market Research2.
  • Projected to grow at a CAGR of 7 percent over the forecast period, the global stroke treatment market is expected to reach a value of approximately BUSD 15 by the year 2027.
  • A rise in the prevalence of stroke across the world, a surge in the elderly patient pool, and rapid rise in comorbidities such as COVID-19, atrial fibrillation, diabetes, and hypertension leading to high risk of developing stroke are anticipated to drive the global stroke treatment market during the forecast period.
  • North America is the leading regional market in the global stroke treatment market and will continue to have a major share throughout the forecast period of 2019 to 2027.
  • The stroke treatment market in Asia Pacific is expected to expand at a high CAGR of 8 percent during the forecast period.
  • An effective new treatment is expected to greatly expand the market as no effective medicine is currently available for the treatment of serious stroke like SAH.
  • A unique and effective drug for SAH is expected to obtain favorable pricing due to the high medical, societal and human cost of the disease.